Home>Entertainment>Elon Musk Reveals Brain Chip Allows Patient To Control Computer Mouse With Thoughts
Entertainment
Elon Musk Reveals Brain Chip Allows Patient To Control Computer Mouse With Thoughts
Published: February 21, 2024
Stay updated with the latest news as Elon Musk unveils groundbreaking brain chip technology enabling patients to control computer mouse with their thoughts.
(Many of the links in this article redirect to a specific reviewed product. Your purchase of these products through affiliate links helps to generate commission for Splashnewsonline.com, at no extra cost. Learn more)
Table of Contents
Elon Musk, the tech billionaire, has announced that the first person to receive Neuralink’s brain chip implant can now control a computer mouse using only their thoughts. This groundbreaking development was revealed by Musk during an X Spaces event, where he shared that the patient, who was part of Neuralink’s initial human test group, has shown positive progress since receiving the implant last month.
Key Takeaway
Elon Musk has revealed that the first recipient of Neuralink’s brain chip implant can control a computer mouse using their thoughts, marking a significant advancement in neurotechnology and its potential to restore functionality to individuals with physical disabilities.
Advancements in Neurotechnology
The patient, according to Musk, has experienced no adverse effects from the implant and has demonstrated the ability to move the computer mouse up and down and drag boxes on the screen through pure thought. The brain chip, named Telepathy, is designed to enable individuals to control electronic devices such as phones and computers using their minds.
The Telepathy Device
Neuralink’s brain chip, known as Telepathy, consists of an electrode with over 1,000 flexible conductors that can be implanted into the cerebral cortex using a surgical robot. These electrodes are programmed to interpret thoughts related to motion, marking a significant leap in neurotechnology.
Human Trials and Future Implications
The first human trial of Neuralink’s brain chip involved a person who had lost the use of their limbs. This trial, which was authorized by the FDA in May 2023, showcases the potential of neurotechnology in restoring functionality to individuals with physical impairments.